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ABSTRACT : We carried out investigations on muscarinic acetylcholine receptors 
(m-AChR) in the rat heart, including the atrioventricular (AV) node. The related tissue 
sections were incubated with 3H-quinuclidinyl benzilate (3H-QNB), then autoradiography 
and an image analysis coupled with computer-assisted microdensitometry were done. 
A single type of specific and high affinity binding sites of 3H-QNB was found to be highly 
concentrated in the AV node, the maximum binding capacity (Bmax) being 1.4 pmol/mg 
protein and with a dissociation constant (Kd) of 0.5 nM. The density and affinity of 
the binding to the AV node were the highest, when compared with findings in the atrium 
(interatrial septum) and ventricle (interventricular septum). The binding was competitively 
displaced by AF-DX 116, a selective antagonist for the M2 AChR subtype, with a high 
affinity, whereas pirenzepine, an antagonist for the M1 AChR subtype was much less 
potent in displacing the binding. Therefore, vagal-cholinergic stimulation presumably 
plays a significant role in functions of the rat AV node, probably by interacting with 
the specific, high affinity M2 AChR subtype.
       INTRODUCTION 
 Vagal-efferent neurons are widely distributed 
in cardiac tissues and densely innervate the 
sinoatrial node and atrioventricular (AV) node, 
a specialized cardiac conduction system?) 
Vagal-cholinergic stimulation exerts negative 
choronotropic and inotropic actions, through 
muscarinic acetylcholine receptors (m-AChR) s> 
Specific acetylcholine-activated single channel 
K+ currents in isolated pacemaker cells were 
recorded using patch-clamp methods and the 
findings differed from events seen in atrial and 
ventricular cells l4> 16> Although there is evidence 
that the M2 AChR subtype in the mammalian
heart is more abundant than the M1 sub-
type, >6>'> little is known of characteristics of 
m-AChR in conduction systems in th heart. 
Distribution and characterization of the ,8-
adrenergic receptors in the rat and guinea pig 
heart areas have been extensively studied. It 
was found that the AV node, an area richly 
innervated by sympathetic nerves, has highly 
dense binding sites for 125I-cyanopindolol, a 
radiolabeled ligad for (.9-adrenergic recep-
tors l2> 15> Of particular interest is the observation 
made by Molenaar et al12> of a higher proportion 
of 8-1 to 8-2 adrenergic receptor present in the 
conduction system, as compared with that of 
the surrounding myocardium. Using the quan-
titative receptor autoradiographic method 11)21)
with 3H-quinuclidinyl benzilate (3H-QNB), a 
radiolabeled ligand for m-AChR,12) we charac-
terized the m-AChR in the rat heart, including 
the AV node.
   MATERIALS AND METHODS 
Animals and sample preparations 
 Twenty five male Wistar rats weighing 250-
300g were fed standard chow (F-2, Funabashi 
Farm Co., Japan), and water ad libitum, and 
housed at 24°C with lights on 06: 00 to IS: 00. 
These rats were decapitated between 16: 00 and 
18: 00, the heart was rapidly removed and placed 
in 3 mM HEPES buffer, pH 7.4, containing 140 
mM NaCl, 5 mM KC1, 1.0 MM MgC12, 1.5 mM 
CaCl2 and 11 mM glucose for 20 sec at 24CC to 
remove the blood. The tissues containing the 
AV node were then immediately dissected under 
the orientation for the tricuspid valves, coronary 
sinus and fossa ovalis, using the method of Saito 
et al. 11)23) frozen in isopentane at -30°C, and 
stored at -80CC. Within 24 hr, frozen, 16 gm-thick 
sections were cut in a cryostat at -16'C, and 
thaw-mounted into gelatin-coated glass slides. 
Sections adjacent to related tissue sections for 
the binding studies were treated using Karn-
ovsky's acetylcholinesterase-staining method"), 
for orientation of localization of the AV node. 
Alternate, unstained sections were stored over-
night, under vacuum at 4°C.
Quantitative receptor autoradiography 
 The unstained sections were labeled with 
3H-QNB (specific activity 30 Ci/mmol , New 
England Nuclear, U. S. A) in the incubation 
medium of 100 .mM sodium phosphate buffer, 
pH 7.4, at 24CC, 30 min.) Saturation experiments 
at equilibrium were performed in the presence 
of increasing amounts of 3H-QNB, ranging from 
123 pM to 8.0 nM, without or with 5.0 MM 
atropine for non-specific binding. In the kinetic 
studies to distinguish and characterize 3H-
QNB binding to the heart tissues, we used three 
antagonists, atropine, AF-DX 116,5)') and 
pirenzepines) After incubation, the slides were 
washed twice (2 sec each) in the same buffer, 
then rinsed quickly in distilled water. Tissue 
sections were dried under a cold stream of air, 
and exposed for 30 to 90 days with calibrated
3H-standards , prepared as described,") to 3H-
Ultrofilm (LKB Industries, U. S. A). The films 
were developed with a D19 Kodak developer, and 
optical densities were measured by computer-
ized microdensitometry (UHG-101, Unique 
Medical Co, Japan). We measured the optical 
densities at four spots in each area of the 
autoradiograms, using a computerized micro-
densitometer. The computer automatically 
averaged the value. The data obtained from 
one rat was calculated from triplicate tissues 
sections. The optical densities observed were 
related to concentration of the radioactivity 
present, as deduced from a comparison with the 
standard curves.
Data analysis 
 Data obtained from the radioligand saturation 
binding studies were analyzed using a LIGAND 
computer program 131 The inhibition constant 
(ICso) values form displacement curves were 
calculated, using the logit-log plot. Results are 
expressed as means ± SEM. Differences were 
analyzed by one-way analysis of variance 
(ANOVA) using the F-test, followed by a 
modified t-test.
Drugs 
 AF-DX 116 and pirenzepine dihydrochloride 
were donated by Dr. Karl Thomae GmbH, 
Federal Republic of Germany, and Nippon 
Boehringer Ingelheim Co., Japan, respectively. 
(-)-Propranolol was a gift form ICI Pharma Co., 
Japan. Atropine sulfate and reagents used were 
purchased form Sigma Chemical Co., U. S. A.
          RESULTS 
 In the initial experiment, we found that 
specific binding of 3H-QNB, obtained at the 
amount of 8.0 nM to the related sections reached 
the maximum at 5 min of incubation time, and 
maintained a plateau for up to 90 min at 24CC. 
 The AV node in the Wistar rat was localized 
in the area between the interatrial septum and 
the interventricular septum and was heavily 
stained for acetylcholinesterase (Figure 1-a). As 
expected, there was a high density of 3H-QNB 
binding to the AV node, whereas a relatively 
low density of the binding was detected in the
Fig 1. Receptor autoradiographic evidence of 3H-
      QNB binding sites in the atrioventricular
      (AV) node, interatrial septum (IAS) and 
       interventricular septum (IVS). Sixteen-,um 
      thick sections were incubated with 8.0 nM 
      3H-QNB in the absence (b, total binding) and 
       presence (c, non-specific binding) of 5.0,uM
      atropine. After incubation, dried sections 
      were exposed to 3H-Ultrofilm for 30 days. 
      A picture of (a) adjacent to (b) is a Karn-
       ovsky's acetylcholinesterase- stained sec-
      tion.
Fig 2. Typical saturation experiments at equilib-
      rium of specific 3H-QNB binding to the 
      atrioventricular (AV) node (0), interatrial
      septum (•) and interventricular septum 
      (A)(upper panel). Scatchard plots (middlE 
      panel) were obtained using the program 
      LIGAND, based on data from saturation 
       curves. Displacement curves (lower panel' 
      of specific 3H-QNB binding to the AV nodE 
      were obtained from the incubation with 8.; 
      nM of the radiolabeled ligand in the
       presence of increasing concentrations of
      atropine (0), AF-DX 116 (0), pirenzepine (A
       and (-) -propranolol (X).
interatrial and interventricular septa (Figure 
1-b). Non-specific binding was less than 2% of 
the total binding (Figure 1-c). 
 In an equilibrium binding study done in the 
presence of increasing concentrations of the 
radiolabeled ligand, specific 3H-QNB binding to 
the AV node was saturable. Scatchard analysis 
of the data obtained from a LIGAND computer 
program") gave a straight line, thereby indi-
Table 1. Dissociation constant (Kd) and maximum binding capacity (Bmax) of "H-QNB binding sites in 
        the rat atrioventricular (AV) node, interatrial septum (IAS), and interventricular septum (IVS)
                           Kd (nM) Bmax (pmol/mg protein) 
AV node 0.477 ± 0.013 a 1.422 ± 0.029 d 
IAS 1.321 ± 0.299 b 1.245 ± 0.049 e 
IVS 1.336 ± 0.198 c 0.503 ± 0.042 f
Results are means ± SEM of 3 individual rats. 
One-way ANOVA, p<0.01 (f<d, F=329.16; f<e, F=132.53), p <0.05 (a<c, F=18.77; a <b, F=7.97; e<d, 
F=9.55)
Table 2. Inhibition (IC50, /-IM) of 3H-QNB binding to the a atrioventricular (AV) node, interatrial septum 
        JAS) and interventricular septum (IVS) by muscarinic antagonists
  Antagonists AV node IAS IVS 
Atropine (4) 0.029 ± 0.009 a 0.091 ± 0.022 b 0.121 ± 0.036 e 
AF-DX 116 (5) 1.729 ± 0.352 d 2.698 ± 1.025 e 3.663 ± 1.039 f 
Pirenzepine (4) 15.018 ± 3.288 g 19.771 ± 0.858 h 19.430 ± 3.806 i 
Propranolol (4) 100000 < 100000 < 100000 <
The IC5o is the concentration of antagonist displacing 50% of specifically bound 3H-QNB obtained at the 
concentration of 8.7 nM. Results are means ± SEM of 4 to 5 individual rats. 
One-way ANOVA, p<0.01 (a<d, F=1.16; d<g, F=20.8; e<h, F=151.59; f<i, F=19.79) 
p<0.05 (a<d, F=6.89; a<c, F=6.36; c<f, F=9.19)
cating that 3H-QNB binds to a single population 
of sites (Figure 2, upper and middle panels). 
A single population of saturable binding sites 
was noted in the interatrial and interventricular 
septa. As summarized in Table 1, the dissocia-
tion constant (Kd) of the binding to the AV node 
was the lowest, and the maximum binding 
capacity (Bmax) was the highest, among 'the 
areas studied. The Bmax of the binding in the 
interatrial septum was significantly higher than 
that in the interventricular septum. 
 Typical inhibition curves of 3H-QNB binding 
to the AV node by atropine, AF-DX 116, pi-
renzepine, and (-)-propranolol are illustrated 
in the lower panel of Figure 2. Atropine and 
AF-DX 116 competitively displaced the binding, 
with a high affinity, and pirenzepine was much 
less potent. Atropine showed the highest po-
tency and (-)-propranolol did not displace the 
binding as shown in IC50 values (Table 2).
         DISCUSSION 
 The quantitative receptor autoradiographic 
method we used revealed that specific 3H-QNB 
binding sites are highly localized in the AV 
node, and area richly innervated with vagal-
cholinergic neurons s> Tissue quenching of 
radioisotope energy in quantitative receptor 
autoradiography with tritiated ligands is one 
factor linked to receptor-transmitter mismatch 
and to the failure to attain precise quantitations 
of receptors in myelin-rich areas such as brain 
white matter. )1) The autoradiographic localiza-
tion of specific 3H-QNB binding sites we noted 
in areas of the heart corresponds to the 
histochemical distribution of acetylcholines-
terase, a finding which differs from data on the 
central nervous system. As cardiac tissues are, 
innervated by un-myelinated nerve fibers; 
quenching was not taken into consideration in 
the present study. 
 We firstly obtained data on difference in the 
affinity of specific 3H-QNB binding between the 
AV node, atrial and ventricular tissues. Binding 
to the AV node had three times the affinity of 
binding to the interatrial and the interven-
tricular septa. Although there are no documen-
ted, comparable data on the affinity of 3H-QNB 
binding to the AV node, there is a difference 
between the Kd value of 1.3 nM in the atrial 
and ventricular septa and that of 0.6 nM noted 
in the rat cardiac membranes by Waelbroeck 
et al.,18> perhaps because of different experi-
mental conditions. AF-DX 116, an antagonist 
for the M2 AChR subtypes)') potently competed 
for binding of 3H-QNB to the AV node, whereas 
pirenzepine, an antagonist for the M1 subtype 16-
was much less potent. ACh seems to modify 
pacemaking functions of the AV nodal cells by 
activating the muscarinic-gated potassium 
channel.") 16) Therefore, taken in conjunction 
with evidence of the anatomical distribution of 
vagal-cholinergic neurons, 9) our data support the 
proposal that the functional significance of 
acetylcholine on the AV node predominantly 
involves the high affinity M2 AChR subtype. 
 The existence of multiple subtypes of m-
AChR has been suggested') The M1 subtype 
is mainly located in the cerebral cortex and 
hippocampus, whereas the M2 subtype with a 
low affinity for pirenzepine is in the heart, 
cerebellum and ileum!')") We characterized 
3H-QNB binding sites in the heart areas , using 
atropine, AF-DX 116 and pirenzepine. When 
comparing the IC5o values obtained from the 
displacement study, atropine, a non-selective 
antagonist was the most potent competitor for 
the binding. Our observations of the potency 
in displacing 3H-QNB binding of three 
muscarinic antagonists is compatible with the 
findings of Watson et a1.19) and of Yamada e2 
a121) Taking note of the recent finding that the 
in vivo potency in the chronotropic action of 
atropine was 10 to 100 times higher than that 
of AF-DX 116, )11) the difference between the 
IC50 values of atropine and AF-DX 116 obtained 
here seems reasonable. As AF-DX 116 was a 
more potent competitor, as compared with 
pirenzepine, it seems likely that the M2 AChR 
subtype is predominantly distributed in heart 
areas. Although the affinity of 3H-QNB binding 
to the AV node was significantly higher than 
in the atrial and ventricular tissues, the potency 
in displacing of AF-DX 116 and pirenzepine was 
similar among the areas studied, the exception 
being the case of atropine. This may contradict 
the finding that AV nodal cells have a specific 
acetylcholine-activated K+ channel and differs 
from electrophysiological evidence obtained 
using atrial and ventricular cells!') 16) Whether 
or not M2 AChR in the AV node is distinct from 
the receptor in atrial and ventricular cells will 
probably be elucidated when more is known of
the molecular properties of 3H-QNB binding 
proteins. 
 In summary, we found specific 3H-QNB 
binding sites to be highly concentrated in the 
AV node and to be characteristically of the 
M2 AChR subtype. Therapeutic approaches to 
treatment of tachy- and bradyrhythmia with 
agents selectively affecting M2 AChR subtype 
may have to be designed.
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